Clinical trial
Clinical Evaluation of the Effectiveness and Safety of Resective Epilepsy Surgery for Tuberous Sclerosis Complex Related Epilepsy
NCT04198181 is registered in ClinicalTrials.gov with Beijing Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Effectiveness and Safety of Resective Epilepsy Surgery for Tuberous Sclerosis Complex Related Epilepsy
- Lead sponsor
- Beijing Children's Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- December 12, 2019
- Completion date
- March 15, 2027
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy, tuberous sclerosis complex